We Give Shareholders a Voice
Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of AMERI Holdings, Inc. (“Ameri” or the “Company”) (NASDAQ: AMRH) to Jay Pharma Inc. (“Jay Pharma”). Under the terms of the agreement, the shareholders of Jay Pharma will become the majority holders of Ameri’s outstanding stock by way of an amalgamation. Following the amalgamation, current Ameri shareholders will own approximately 16% of the combined company and current Jay Pharma shareholders will own approximately 84% of the combined company.
The Ameri merger investigation concerns whether the Board of Ameri breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction and whether Jay Pharma is underpaying for Ameri shares, thus unlawfully harming Ameri shareholders.
To receive more information, please fill out the form.